RT @jmanclus60: Aquí está el artículo publicado en Cancer Research (revista de alto impacto en el campo), en el cual publican las propiedad…
Aquí está el artículo publicado en Cancer Research (revista de alto impacto en el campo), en el cual publican las propiedades del fármaco (inhibidor de la actividad enzimática de las SRC kinasas)👇 https://t.co/HmkxJrmGqC
A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and Tolerability https://t.co/RBLjjpRORa
RT @BOOMchemistry: 10 years of research culminates with this work. Our most important contribution to the cancer field. Joint effort from @…
RT @BOOMchemistry: 10 years of research culminates with this work. Our most important contribution to the cancer field. Joint effort from @…
RT @CIB_CSIC: #CIBpapers A novel mode of inhibiting SRC improves drug efficacy and tolerability. A paper published in Cancer Research (@CR…
RT @CIB_CSIC: #CIBpapers A novel mode of inhibiting SRC improves drug efficacy and tolerability. A paper published in Cancer Research (@CR…
RT @CIB_CSIC: #CIBpapers A novel mode of inhibiting SRC improves drug efficacy and tolerability. A paper published in Cancer Research (@CR…
#CIBpapers A novel mode of inhibiting SRC improves drug efficacy and tolerability. A paper published in Cancer Research (@CR_AACR) with the collaboration of Dr. Lietha's team and Juan Luque at @CIB_CSIC. Details here: ➡️https://t.co/ddPG7Wtt6A https://t.
RT @htpu_services: We were delighted to provide RPPA and NanoString data for this excellent paper. Congratulations to @BOOMchemistry and ev…
RT @BOOMchemistry: 10 years of research culminates with this work. Our most important contribution to the cancer field. Joint effort from @…
RT @BOOMchemistry: 10 years of research culminates with this work. Our most important contribution to the cancer field. Joint effort from @…
RT @BOOMchemistry: 10 years of research culminates with this work. Our most important contribution to the cancer field. Joint effort from @…
RT @BOOMchemistry: 10 years of research culminates with this work. Our most important contribution to the cancer field. Joint effort from @…
RT @BOOMchemistry: 10 years of research culminates with this work. Our most important contribution to the cancer field. Joint effort from @…
RT @BOOMchemistry: 10 years of research culminates with this work. Our most important contribution to the cancer field. Joint effort from @…
RT @BOOMchemistry: 10 years of research culminates with this work. Our most important contribution to the cancer field. Joint effort from @…
RT @BOOMchemistry: 10 years of research culminates with this work. Our most important contribution to the cancer field. Joint effort from @…
RT @BOOMchemistry: 10 years of research culminates with this work. Our most important contribution to the cancer field. Joint effort from @…
RT @BOOMchemistry: 10 years of research culminates with this work. Our most important contribution to the cancer field. Joint effort from @…
RT @htpu_services: We were delighted to provide RPPA and NanoString data for this excellent paper. Congratulations to @BOOMchemistry and ev…
We were delighted to provide RPPA and NanoString data for this excellent paper. Congratulations to @BOOMchemistry and everyone else involved!
RT @BOOMchemistry: 10 years of research culminates with this work. Our most important contribution to the cancer field. Joint effort from @…
RT @BOOMchemistry: 10 years of research culminates with this work. Our most important contribution to the cancer field. Joint effort from @…
10 years of research culminates with this work. Our most important contribution to the cancer field. Joint effort from @EdinCRC, @MRC_CRH and @CIB_CSIC!! https://t.co/Ih9SrFi44w